Elsevier is pleased to announce the publication of Comprehensive Biomaterials, 6-volume set, edited by Paul Ducheyne (Editor-in-Chief), Kevin Healy, Dietmar Hutmacher, James Kirkpatrick and David Grainger (co-Editors).
Materials technologies relevant to advancing biomaterials toward clinical applications span an enormous and unprecedented intellectual and technological bandwidth. Areas to consider now include aspects of molecular, computational, recombinant, biotechnological, synthetic combinatorial, nanotechnological, hybrid composite, microbial, cell- and tissue-based, device innovation and quality systems management, preclinical and clinical testing, regulatory dimensions, and life-cycle analytical contributions to the global field and associated industry.  
Comprehensive Biomaterials develops most of this ‘bandwidth’ significant to the biomaterials field. The result is a continuum of rich information appropriate for many audiences from expert contributors. The treatise addresses the current status of nearly all biomaterials in the field, their strengths and weaknesses, their future prospectus, appropriate analytical methods and testing, device applications and performance, emerging candidate materials as competitors and disruptive technologies, and strategic insights for those entering and operational in diverse biomaterials applications, research and development, regulatory management, and commercial aspects.
For more information, including sample content, please visit:
Available August 2011
Hardback : 3750 pages
Print ISBN: 978-0-08-055302-3
Print list price: $3820.00/€2700.00/£2295.00
Print introductory price: $ 2995.00/2140.00/£1820.00

Electronic ISBN: 978-0-08-055294-1